LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 126 filers reported holding LEXICON PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 4.22 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $17,977 | -18.0% | 16,493 | +72.4% | 0.00% | – |
Q2 2023 | $21,911 | -77.9% | 9,568 | -55.5% | 0.00% | – |
Q2 2021 | $99,000 | -13.2% | 21,505 | +10.7% | 0.00% | – |
Q1 2021 | $114,000 | +7.5% | 19,422 | -37.3% | 0.00% | – |
Q4 2020 | $106,000 | -95.7% | 30,970 | -98.2% | 0.00% | -100.0% |
Q3 2020 | $2,462,000 | -27.8% | 1,709,776 | 0.0% | 0.01% | -25.0% |
Q2 2020 | $3,411,000 | +143.6% | 1,709,776 | +138.2% | 0.01% | +100.0% |
Q1 2020 | $1,400,000 | +200.4% | 717,707 | +538.5% | 0.00% | +300.0% |
Q4 2019 | $466,000 | +46500.0% | 112,397 | +158205.6% | 0.00% | – |
Q3 2019 | $1,000 | -98.4% | 71 | -99.3% | 0.00% | – |
Q2 2019 | $62,000 | -11.4% | 9,862 | -21.8% | 0.00% | – |
Q1 2019 | $70,000 | +1066.7% | 12,611 | +1317.0% | 0.00% | – |
Q4 2018 | $6,000 | -92.3% | 890 | -79.3% | 0.00% | – |
Q3 2016 | $78,000 | – | 4,294 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ulys, L.L.C. | 4,321,214 | $25,366,000 | 100.00% |
Artal Group S.A. | 71,178,364 | $417,817,000 | 7.38% |
BVF INC/IL | 8,394,000 | $49,273,000 | 1.85% |
Boothe Investment Group, Inc. | 435,939 | $2,559,000 | 1.49% |
Campbell & CO Investment Adviser LLC | 103,100 | $605,000 | 0.37% |
NEA Management Company, LLC | 2,382,286 | $13,984,000 | 0.31% |
PINNACLE ASSOCIATES LTD | 2,167,172 | $12,721,000 | 0.24% |
Eversept Partners, LP | 410,593 | $2,410,181 | 0.18% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $210,000 | 0.12% |
OCCUDO QUANTITATIVE STRATEGIES LP | 66,299 | $389,000 | 0.08% |